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Diagnosis of cardiac involvement is important for the manage-
ment of patients with systemic sclerosis (SSc). This study was
undertaken to determine the significance of gated myocardial
perfusion SPECT in patients with SSc and whether diastolic
function measured by gated SPECT is an early sign of cardiac
complications. Methods: Thirty-four patients with SSc and 16
control patients were studied using exercise nongated and rest-
ing gated myocardial perfusion SPECT. The SSc was classified
by the modified Rodnan total skin score (TSS) into high-TSS
(score $ 10; n 5 18) and low-TSS (score , 10; n 5 16) groups.
Gated SPECT was performed using 99mTc-methoxyisobutyl-
isonitrile with 16 frames per cardiac cycle and quantitatively
analyzed by QGS software and Fourier filtering of the volume
curve. The parameters of ejection fraction (EF), peak filling rate
(PFR), one-third mean filling rate, and time to PFR (TPFR) were
calculated. Results: A slight perfusion abnormality was ob-
served in four and five patients in the low-TSS and high-TSS
groups, respectively (not statistically significant). A decreased
resting EF less than 55% was found in no and two patients in
the low-TSS and high-TSS groups, respectively. TPFR was
166 6 22, 168 6 38, and 216 6 82 ms (P 5 0.05, high-TSS
group versus low-TSS group; P 5 0.04, control group versus
high-TSS group) and TPFR/R-R interval was 0.18 6 0.02,
0.19 6 0.04, and 0.26 6 0.09 (P 5 0.01, high-TSS group versus
low-TSS group; P 5 0.005, control group versus high-TSS
group) for the control, low-TSS, and high-TSS groups, respec-
tively. Conclusion: Diastolic function can be evaluated by gated
myocardial perfusion SPECT. Significant diastolic abnormalities
were shown even in patients with normal perfusion and systolic
function and were related to the severity of SSc.
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Cardiac involvement in systemic sclerosis (SSc) in-
cludes arrhythmias, pericarditis, angina pectoris, congestive
heart failure, and sudden death (1–5). Because renal in-
volvement is no longer a major cause of death in SSc,
cardiopulmonary involvement has been considered to be an
important prognostic factor (5,6). Although the origin of the
disease has not been fully understood, focal myocardial
lesions ranging from contraction band necrosis to fibrosis
(1–3) and reversible vasospastic abnormality in small cor-
onary arteries (7,8) have been found to be an important
mechanism in myocardial dysfunction.
Nuclear medicine studies with 201Tl have shown that
stress-induced ischemia and perfusion defects occur in the
SSc group (4,7–11). A reduced coronary flow reserve has
also been shown (11). However, our experience with SSc
patients has been that perfusion defects and large areas of
induced ischemia do not seem to be so common as de-
scribed previously.
Recently, gated SPECT has become a common procedure
in patients with ischemic heart disease (12,13). This quan-
titative technique has not, however, been used in patients
with SSc. Moreover, although, in cases of ischemic heart
disease, hypertension, and cardiomyopathy, myocardial in-
volvement has been detected early by an evaluation of
diastolic abnormalities (14–18), the feasibility of applying
gated SPECT to assessment of diastolic function has not
been investigated.
Thus, we hypothesized that gated perfusion SPECT can
detect functional abnormalities earlier and more accurately
than conventional nongated 201Tl perfusion studies. Even if
a perfusion defect is not observed, quantitative analysis of
left ventricular contractility may detect functional abnor-
malities in an SSc population. Even if systolic dysfunction
is not observed, some diastolic abnormalities may be
present in the early stages of SSc. We investigated the
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feasibility of evaluating the diastolic phase with gated
SPECT.
MATERIALS AND METHODS
The study group consisted of 34 patients (3 men, 31 women;
mean age 6 SD, 56 6 13 y) who were diagnosed with SSc in our
dermatology department on the basis of the diagnostic criteria of
the American Rheumatism Association (19). The final diagnosis,
for hospitalized patients, was based on skin lesions and a general
work-up of organ involvement including the lung, heart, kidney,
and digestive system. The skin lesions were scored by the total
skin score (TSS) as described below (20–22). The classification
into diffuse and limited cutaneous SSc types was based on skin
lesions, other clinical findings, and laboratory data, according to
the method of LeRoy et al. (20). Patients with atrial fibrillation
were excluded because the electrocardiogram (ECG) gating was
expected to be inaccurate. Patients with other connective tissue
disorders, such as polymyositis, dermatomyositis, systemic lupus
erythematosus, and sarcoidosis, were also excluded, so that in-
volvement by SSc alone could be evaluated. Exercise ECG, Holter
ECG, and two-dimensional echocardiography were performed on
all patients. The diffusing capacity of the lung was determined by
carbon monoxide measurements. The glomerular filtration rate of
the kidneys was measured using 99mTc DTPA and the method of
Gates (23).
The control patients for gated SPECT consisted of 16 age-
matched and sex-ratio–matched patients (2 men, 14 women; mean
age, 50 6 12 y). Treadmill-exercise ECG and gated 99mTc-me-
thoxyisobutylisonitrile studies both at rest and during exercise
were performed to rule out the possibility of angina pectoris (n 5
12) and to monitor cardiac side effects before chemotherapy of
lymphoma (n 5 4). Echocardiography showed a normal chamber
size, a normal wall thickness, and good ventricular contractility.
The exercise study found no significant ECG changes indicating
myocardial ischemia. The patients had no complications from
diabetes mellitus or hypertension and were thus judged to have a
low likelihood of cardiac disease.
TSS
Semiquantitative scoring of skin lesions was based on modified
Rodnan criteria (21,22). The scleroderma was scored from 0
(normal) to 3 (severe) for 17 body surface areas. The summed skin
score ranged from 0 to 51. In this study group, the mean TSS was
12 6 9 and the range was 1–35.
Exercise and Resting Perfusion Imaging
The exercise study was performed using a supine bicycle er-
gometer, which started at 25 W and increased by 25 W. During
symptom-limited peak exercise, 300–370 MBq 99mTc-methoxy-
isobutylisonitrile were intravenously injected and the exercise was
continued for an additional 60–90 s. The second administration
dose, for the resting study, was 600–740 MBq. The SPECT
acquisition was started at least 40 min after each injection.
SPECT Data Acquisition and Reconstruction
A three-detector SPECT system (GCA 9300A/UI; Toshiba,
Tokyo, Japan) was used for data acquisition and analysis. A total
of 60 projection images were obtained, with 64 3 64 matrices over
360°. The acquisition time was 45 s for each projection. Hardware
zooming was used for small patients (24). The first postexercise
study was obtained without gating, and the second resting study
was acquired with gating. A cardiac cycle was divided into 16
frames. The R-R interval and heart rate histogram were recorded to
monitor arrhythmia. An average R-R interval of 615% was ac-
cepted for gating.
The SPECT images were reconstructed by a standard filtered
backprojection algorithm using a ramp filter. For preprocessing, a
Butterworth filter with an eighth order and a cutoff frequency of
0.28 cycle/pixel (one pixel 5 0.64 cm) was used. For reconstruc-
tion of nongated images, a Butterworth cutoff filter with a cutoff
frequency of 0.30 cycle/pixel was used.
Analysis
Three nuclear medicine physicians visually judged exercise-
induced ischemia and regional perfusion defects without knowing
the severity of the skin lesions and reached a consensus. Both the
gray-scale display on the film and a hard copy with rainbow color
coding were used for interpretation.
Quantitative Gated SPECT (QGS) (version 2; Cedars-Sinai
Medical Center, Los Angeles, CA), a commercially available
software program, was used for calculating ventricular edges,
volume, ejection fraction (EF), and functional maps. The algorithm
for determining edges and calculating volume has been described
and validated by Germano et al. (12,13).
Sixteen values for the ventricular volume were transferred to the
microcomputer. Discrete Fourier transform was performed to cal-
culate direct current components, fundamental frequency, and
high-order harmonics. A fundamental wave and the second-to
fourth-order harmonics were used to generate filtered volume
curves. The filtered differentiation (dV/dt) curve was directly
calculated by Fourier series. Examples of dV/dt parameters for two
patients are shown in Figure 1. The peak filling rate (PFR) was
defined as the maximum dV/dt value divided by end-diastolic
volume (per second). The one-third mean filling rate was calcu-
lated as an average of dV/dt values in the first third of the filling
time (per second). The time to PFR (TPFR) was measured from the
time at end-systole to that at PFR (milliseconds). The ratio of
TPFR (milliseconds) to R-R interval (milliseconds) was also cal-
culated.
Statistical Analysis
Values were expressed as mean 6 SD. Differences in variance
and mean values were examined using a multiple comparisons test
after a significant finding from one-way ANOVA. The Scheffe´ test
was applied. Differences between the two groups were examined
using the Student t test. Differences in the contingency table were




Patients were classified into a high-TSS group (score $
10; mean, 19 6 7) and a low-TSS group (score , 10; mean,
4 6 3). Patient information is summarized in Table 1. No
significant difference in age, age at onset, and disease du-
ration was observed between the high-TSS group and the
low-TSS group. In the low-TSS group, 3 diffuse and 13
limited cutaneous types of SSc were included, whereas in
the high-TSS group, 15 diffuse and 3 limited cutaneous
types were included (P 5 0.0002 between the high-TSS
group and the low-TSS group).
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Perfusion Abnormality
Only a slight degree and a small region of inferoapical
ischemia were suspected in two patients in the low-TSS
group and one patient in the high-TSS group (not statisti-
cally significant [NS]). A slight degree of resting myocar-
dial hypoperfusion was observed in two and three patients
in the low- and high-TSS groups, respectively (NS). Either
slight ischemia or hypoperfusion was seen in four and five
patients in the low- and high-TSS groups, respectively (NS)
Parameters Based on Gated SPECT
Parameters calculated by QGS software and Fourier fit-
ting are shown in Table 2. Heart rate and end-diastolic
volume did not differ significantly among the groups. Al-
though average EF did not differ significantly among the
groups, two patients in the high-TSS group had an EF less
than 55%. These two patients had high skin scores (30 and
24). The fractional shortening measured on echocardiogra-
phy was 37% 6 5% and 41% 6 6% in the low- and
high-TSS groups (P 5 NS), respectively. The PFR did not
differ significantly among the groups. The one-third mean
filling rate was slightly low in the high-TSS group (P 5
0.017). The TPFR and TPFR/R-R interval were increased in
the high-TSS group (P 5 0.015 and 0.002, respectively). If
an abnormal TPFR/R-R interval is defined as $ 0.22 (av-
erage 1 2 SD of the control group), abnormal filling was
observed in one (6%), three (18%), and nine (50%) patients
in the control, low-TSS, and high-TSS groups (P 5 0.01),
respectively.
Other Abnormalities
In the high-TSS group, Holter ECG showed frequent mul-
tiform premature ventricular contractions (PVC) in four pa-
tients, a second-degree atrioventricular block (Wenckebach
block) in one patient, and an incomplete right bundle branch
block in one patient. Frequent PVC or supraventricular prema-
ture contractions (SVPC) was seen in two patients with a low
TSS and in six patients with a high TSS (NS). Sporadic
innocent PVC and SVPC were observed in 10 and 12 patients
in the low- and high-TSS groups, respectively (NS). The ST-T
abnormality was observed in only one patient in the high-TSS
group. The glomerular filtration rate of both kidneys was 87 6
23 mL/min and 72 6 21 mL/min for the low- and high-TSS
groups (P 5 0.057 [NS]), respectively, although the latter
group showed a relatively low glomerular filtration rate. The
diffusing capacity measured by carbon monoxide diffusion in
the lung was significantly low in the high-TSS group (52% 6
21%, P 5 0.017) compared with that in the low-TSS group
(69% 6 15%).
DISCUSSION
Autopsy findings of myocardial fibrosis in SSc have been
reported to be common (1–3). Clinical diagnosis of myo-
cardial involvement, however, is less frequent. When cu-
mulative survival rate was analyzed (5), heart involvement
was one of the most important prognostic factors. If the
heart was involved, lung involvement made little difference
FIGURE 1. Examples of volume curves from two patients with SSc. Open circles are original data points. (A) Patient with limited
cutaneous type and low TSS. All parameters of volume curve are within normal range. (B) Patient with diffuse cutaneous type and
high TSS. Volume curve indicates low one-third mean filling rate (1/3MFR) and increased time to peak filling rate (TPFR). HR 5 heart
rate; PFR 5 peak filling rate.
TABLE 1
Classification by TSS
Parameter Low TSS High TSS P
n 16 18
Age (y) 56 6 10 55 6 15 NS
Age of onset (y) 44 6 15 46 6 17 NS
Disease duration (y) 13 6 12 7 6 13 NS





4.0 6 2.5 19.2 6 6.7 ,0.0001*
*Definition of classification.
NS 5 not statistically significant.
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in survival rate. The simplest way to assess cardiac involve-
ment clinically is through ECG, which evaluates arrhyth-
mias and conduction abnormalities. In addition, pericarditis,
congestive heart failure, or low voltage was observed. Con-
sidering the poor prognosis in patients with cardiac involve-
ment, quantitative methods are desirable for early diagnosis,
treatment monitoring, and prognostic evaluation.
For classification, we used the modified Rodnan method,
which has been in recent international use to quantify the
severity of SSc. The score is based on cutaneous thickness
assessed for 17 body surface areas using a 0–3 scale. Good
reproducibility has been reported for the scoring technique,
and the score has correlated with the severity of disease
activity (21,22,25). Diffuse scleroderma associated with a
high TSS has indicated a poor prognosis and a high inci-
dence of involvement in other organs, such as the kidney,
heart, and lungs. This classification has generally matched
well with the limited and diffuse cutaneous types reported
by LeRoy (20).
Myocardial perfusion studies, mainly using 201Tl, have
been performed to investigate stress-induced ischemia and
myocardial damage. Using exercise 201Tl and radionuclide
ventriculography, Follansbee et al. (4) studied 26 patients
with SSc and found that 20 patients showed abnormal
findings on thallium scans, including 10 with reversible
ischemia and 18 with fixed defects. The mean resting EF
was also lower in patients with a perfusion defect. In pa-
tients with larger thallium perfusion defects, a significantly
increased risk of subsequent cardiac events or death has also
been reported (10). Reversible cold-induced ischemia was
found in 10 of 13 patients by a 201Tl study (7). In addition,
reduced coronary flow and reduced perfusion reserve were
reported in seven patients with SSc (11). These findings
have indicated that abnormalities of microcirculation (inter-
mittent vascular spasm or intramyocardial Raynaud’s phe-
nomenon) and focal scattered fibrosis may result in stress-
induced ischemia and manifest as focal defects on a
myocardial perfusion scan.
Compared with these studies, no significant segmental
defect or induced ischemia was observed in this study.
Conversely, we found only a minor degree of perfusion
abnormality. Because scoring by Rodnan TSS was common
even in different hospitals, the low degree of damage we
found is partly explained by differences in disease severity.
Scores of 0–9, 10–35, and more than 35 usually correspond
to SSc that is mild, moderate, and severe, respectively (25).
Thus, our study group might not include the most severe
type of SSc. Another explanation may be differences in the
sex and race of the patients. The previous reports found that
men had a poorer prognosis than women, and racial differ-
ences were also noted (5). Special aspects of the Japanese
population and the prevalence in women in our study may
be the cause of the relatively low degree of myocardial
damage that we found (26,27). The use of 111In-antimyosin
and 123I-metaiodobenzylguanidine has been described
(28,29), but further investigation is necessary to validate
these radiopharmaceuticals.
Abnormalities in diastolic function were found in half the
high-TSS group, although a decrease in EF was observed in
only two patients. Pace et al. (30) reported impaired relax-
ation and diastolic asynchrony in SSc using radionuclide
angiography. However, whether a relationship existed with
the severity of SSc was not evaluated. Because myocardial
fibrosis increases with the progress of SSc, a decrease in left
ventricular contractility may be anticipated. Even patients
with a normal resting EF may have a reduced functional
reserve for exercise, but we did not evaluate EF during
exercise. However, in ischemic heart disease, hypertrophic
cardiomyopathy, and hypertensive heart diseases, diastolic
dysfunction may occur even without any systolic dysfunc-
tion (14–18). Various factors such as myocardial stiffness,
wall elasticity, compliance, incomplete relaxation, and ven-
tricular pressure may be involved in diastolic dysfunction
(31–33), and a similar mechanism may also be at work in
SSc. From our results, we speculate that diastolic abnormal-
TABLE 2
Comparison of Gated SPECT Parameters
Parameter Control Low TSS High TSS
ANOVA
P P between each group
n 16 16 18
Heart rate (per minute) 65 6 7 68 6 11 71 6 8 NS
End-diastolic volume (mL) 73 6 19 55 6 10 58 6 18 NS
Ejection fraction (%) 68 6 9 73 6 9 71 6 12 NS
Ejection fraction , 55% 0 (0%) 0 (0%) 2 (11%) NS
Diastolic parameters
Peak filling rate (PFR) (per second) 2.46 6 0.45 2.76 6 0.44 2.74 6 0.53 NS
One-third mean filling rate (per
second)
1.52 6 0.25 1.57 6 0.31 1.25 6 0.42 0.017 L, H(0.03); C, H(0.08)
Time to PFR (ms) 166 6 22 168 6 38 216 6 82 0.015 L, H(0.05); C, H(0.04)
Time to PFR/R-R interval 0.18 6 0.02 0.19 6 0.04 0.26 6 0.09 0.002 L, H(0.01); C, H(0.005)
NS 5 not statistically significant; L 5 low TSS; H 5 high TSS; C 5 control.
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ity is an early characteristic of myocardial involvement in
SSc.
The reliability of diastolic function has been established
in gated blood-pool studies (14–18,30) but not in gated
myocardial SPECT. In our preliminary study, diastolic
dV/dt parameters derived from gated SPECT with 12
frames per cardiac cycle were compared with those from a
gated blood pool study with 24 frames per cardiac cycle in
20 patients (34). The correlation coefficients were 0.73 for
PFR, 0.85 for one-third mean filling rate, and 0.90 for EF.
Inaccuracy of diastolic parameters, however, has been noted
in some patients. Therefore, we used 16 frames per cardiac
cycle, which is a reasonable compromise in current gated
SPECT studies. To obtain a sufficient myocardial count by
16-frame division, we used a triple-detector system. A dual-
detector system with a rectangular configuration is also an
option for this purpose. To evaluate the diastolic function
more precisely, we used Fourier fitting rather than numeric
calculation of derivatives. The last part of the volume curve
may have been underestimated by fluctuation of the R-R
interval during acquisition. However, because edge detec-
tion was based on gaussian fitting by the QGS software, a
slight count underestimation in the last part would not
influence the volume determined automatically. In fact, we
did not see a sudden drop of curve in the last frames in this
series. Moreover, this study clearly indicated that evaluation
of diastolic function was valid even by gated SPECT stud-
ies. Thus, calculation of diastolic dV/dt routinely, even for
other types of cardiac diseases, may be helpful using a gated
SPECT study if more than a 16-frame division is used.
Patients with atrial fibrillation were not included in this
study because of inaccuracy in evaluating the diastolic
phase. Frequent PVC or SVPC during acquisition will be
inappropriate in gated SPECT. In this series, all patients
showed only a few rejected beats during acquisition. Con-
sequently, the result was considered reliable.
Who are candidates for a gated myocardial study? Pa-
tients with a TSS of 10 or higher should be studied by gated
SPECT, and diastolic function should be carefully evalu-
ated. Patients with a diffuse cutaneous type of SSc are also
good candidates for gated SPECT. Although many patients
may show no clinical symptoms during a routine work-up
for SSc, diastolic dysfunction can be an early sign of cardiac
dysfunction, and patients showing such dysfunction should
be followed up. Moreover, patients in whom Holter ECG
reveals arrhythmia and patients with clinical signs of ische-
mia, effusion, and heart failure should be examined with a
stress perfusion study. Although patients with these severe
manifestations were not included in our population, a study
that includes such patients would help in their management.
Further follow-up studies are required to elucidate whether
diastolic abnormalities are reversible with treatment and
whether they correlate with the progress of systolic and
perfusion abnormalities. Lastly, the prognostic significance
of each parameter should be determined. Compared with
gated blood-pool studies, which can be performed both at
rest and during exercise, gated SPECT can be performed
only at rest. However, the merit of gated perfusion SPECT
is its ability to simultaneously assess exercise–rest perfusion
and resting ventricular function. Because myocardial perfu-
sion SPECT, particularly gated, seems to be underutilized in
this field, such uses should be further investigated.
CONCLUSION
In addition to calculating EF and ventricular volume,
gated SPECT can evaluate diastolic function. Diastolic ab-
normalities, although also observed in patients with normal
perfusion and systolic function, may be an early sign of
cardiac dysfunction in patients with mild to moderate SSc.
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